References
- Yook CS. Coloured medicinal plants of Korean. Seoul: Academy Publishing; 1993. p. 371–372.
- Bae K. The medicinal plants of Korea. Seoul: Kyo-Hak Publishing; 2000. p. 361.
- Shin KH, Lee SH. The chemistry of secondary products from Acanthopanax species and their pharmacological activities. Nat. Prod. Sci. 2002;8:111–126.
- Na MK, Oh WK, Kim YH, Cai XF, Kim SH, Kim BY, Ahn JS. Inhibition of protein tyrosine phosphatase 1B by diterpenoids isolated from Acanthopanax koreanum. Bioorg. Med. Chem. Lett. 2006;16:3061–3064.10.1016/j.bmcl.2006.02.053
- Cai XF, Lee IS, Dat NT, Shen GH, Kim YH. Diterpenoids with inhibitory activity against NFAT transcription factor from Acanthopanax koreanum. Phytother. Res. 2004;18:677–680.10.1002/(ISSN)1099-1573
- Kang OH, Kim DK, Cai XF, Kim YH, Lee YM. Attenuation of experimental murine colitis by acanthoic acid from Acanthopanax koreanum. Arch. Pharm. Res. 2010;33:87–93.10.1007/s12272-010-2230-x
- Nhiem NX, Kiem PV, Minh CV, Tai BH, Tung NH, Ha DT, Soung KS, Kim JH, Ahn JY, Lee YM, Kim YH. Structure-activity relationship of lupane-triterpene glycosides from Acanthopanax koreanum on spleen lymphocyte IL-2 and INF-γ. Bioorg. Med. Chem. Lett. 2010;20:4927–4931.10.1016/j.bmcl.2010.06.044
- Kim JA, Yang SY, Koo JE, Koh YS, Kim YH. Lupane-type triterpenoids from the steamed leaves of Acanthopanax koreanum and their inhibitory effects on the LPS-stimulated pro-inflammatory cytokine production in bone marrow-derived dendritic cells. Bioorg. Med. Chem. Lett. 2010;20:6703–6707.10.1016/j.bmcl.2010.09.001
- Kim JA, Yang SY, Song SB, Kim YH. Effects of impressic acid from Acanthopanax koreanum on NF-кB and PPARγ activities.Arch. Pharm. Res. 2011;34:1347–1351.10.1007/s12272-011-0815-7
- Pande V, Ramos MJ. NF-kappa B in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr. Med. Chem. 2005;12:357–374.10.2174/0929867053363180
- Yamamoto Y, Gaynor RB. Role of the NF-kappa B pathway in the pathogenesis of human disease states. Curr. Mol. Med. 2001;1:287–296.10.2174/1566524013363816
- Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappa B. J. J. Clin. Invest. 2001;107:241–246.10.1172/JCI11991
- Pande V, Ramos M. Inhibitory effect of astragalin on expression of lipopolysaccharide-induced inflammatory mediators through NF-κB in macrophages. Curr. Med. Chem. 2005;12:357–374.10.2174/0929867053363180
- Kim MS, Kim SH. Studies on the constituents of the stem bark of Kalopanax pictus. Arch. Pharm. Res. 2011;34:2101–2107.10.1007/s12272-011-1213-x
- Sano K, Sanada S, Ida Y, Shoji J. Chemical constituents from Acanthopanax senticosus. Chem. Pharm. Bull. 1991;39:865–870.10.1248/cpb.39.865
- Li ZF, Yang JH, Zhang WG, Feng YL, Jian H, Luo XJ, Yang SL, Pei YH. Constituents of the barks of Fraxinus chinensis Roxb. Zhongcaoyao. 2011;42:852–855.
- Wei XL, Yang CH, Liang JY. Glycosides from the stems of Photinia pyrifolia. Zhongguo Tianran Yaowu. 2005;3:228–230.
- Zhang DM, Li Y, Yu SS. Enantioselective synthesis of phenylpropanetriols. Tianran Chanwu Yanjiu Yu Kaifa. 2004;16:496–499.
- DellaGreca M, Fiorentin A, Monaco P, Previtera L. Synth. Commun. 1998;28:3693–3700.10.1080/00397919808004916